5008752025-10-012025-12-315008752025-12-315008752025-04-012025-12-315008752025-10-012025-12-31in-capmkt:OtherExpenses1Member5008752025-10-012025-12-31in-capmkt:OtherExpenses2Member5008752025-04-012025-12-31in-capmkt:OtherExpenses1Member5008752025-04-012025-12-31in-capmkt:OtherExpenses2Member5008752025-10-012025-12-31in-capmkt:ReportableSegments1Member5008752025-10-012025-12-31in-capmkt:ReportableSegments2Member5008752025-10-012025-12-31in-capmkt:ReportableSegments3Member5008752025-10-012025-12-31in-capmkt:ReportableSegments4Member5008752025-10-012025-12-31in-capmkt:ReportableSegments5Member5008752025-04-012025-12-31in-capmkt:ReportableSegments1Member5008752025-04-012025-12-31in-capmkt:ReportableSegments2Member5008752025-04-012025-12-31in-capmkt:ReportableSegments3Member5008752025-04-012025-12-31in-capmkt:ReportableSegments4Member5008752025-04-012025-12-31in-capmkt:ReportableSegments5Member5008752025-10-012025-12-31in-capmkt:ReportableSegments1Member5008752025-10-012025-12-31in-capmkt:ReportableSegments2Member5008752025-10-012025-12-31in-capmkt:ReportableSegments3Member5008752025-10-012025-12-31in-capmkt:ReportableSegments4Member5008752025-10-012025-12-31in-capmkt:ReportableSegments5Member5008752025-04-012025-12-31in-capmkt:ReportableSegments1Member5008752025-04-012025-12-31in-capmkt:ReportableSegments2Member5008752025-04-012025-12-31in-capmkt:ReportableSegments3Member5008752025-04-012025-12-31in-capmkt:ReportableSegments4Member5008752025-04-012025-12-31in-capmkt:ReportableSegments5Member5008752025-10-012025-12-31in-capmkt:ReportableSegments1Member5008752025-12-31in-capmkt:ReportableSegments1Member5008752025-10-012025-12-31in-capmkt:ReportableSegments2Member5008752025-12-31in-capmkt:ReportableSegments2Member5008752025-10-012025-12-31in-capmkt:ReportableSegments3Member5008752025-12-31in-capmkt:ReportableSegments3Member5008752025-10-012025-12-31in-capmkt:ReportableSegments4Member5008752025-12-31in-capmkt:ReportableSegments4Member5008752025-10-012025-12-31in-capmkt:ReportableSegments5Member5008752025-12-31in-capmkt:ReportableSegments5Member5008752025-10-012025-12-31in-capmkt:ReportableSegments1Member5008752025-12-31in-capmkt:ReportableSegments1Member5008752025-10-012025-12-31in-capmkt:ReportableSegments2Member5008752025-12-31in-capmkt:ReportableSegments2Member5008752025-10-012025-12-31in-capmkt:ReportableSegments3Member5008752025-12-31in-capmkt:ReportableSegments3Member5008752025-10-012025-12-31in-capmkt:ReportableSegments4Member5008752025-12-31in-capmkt:ReportableSegments4Member5008752025-10-012025-12-31in-capmkt:ReportableSegments5Member5008752025-12-31in-capmkt:ReportableSegments5Member5008752025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15008752025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15008752025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15008752025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500875ITCNOTLISTEDINE154A01025ITC LimitedMain BoardEquity2025-04-012026-03-312026-01-292026-01-15INRCroresQuarterlyThird quarterMulti segment2026-01-2913:10:002026-01-2918:25:00Not applicable2025-10-012025-12-31UnauditedConsolidated217066400000574040000022280680000067965500000154738000007371000001704060000019470000043082000004702420000015274410000070062700000-354580000066516900000109898000006366500000173563000000491606000000001023900000501845000006942000005087870000049311900000872600000500061000008726000001252900000013.943.94003.943.94 <BR> 1. ‘Revenue from operations’ includes ‘Gross Revenue from sale of products and services’ and ‘Other operating revenue’. <BR> <BR> 2. ‘Purchase of stock-in-trade’ should be read as ‘Purchase of Stock-in-Trade and Biological Assets’. <BR> <BR> 3. ‘Changes in inventories of finished goods, work-in-progress and stock-in-trade’ should be read as ‘Changes in inventories of finished goods, Stock-in-Trade, work-in-progress, intermediates and Biological Assets’. <BR> <BR> 4. ‘Depreciation, depletion and amortisation expense’ should be read as ‘Depreciation and amortization expense’. <BR> <BR> NOTES TO STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31.12.2025 <BR> <BR> 1. The Unaudited Consolidated Financial Results and Segment Results were reviewed by the Audit Committee, and approved by the Board of Directors of the Company at its meeting held on 29th January, 2026. <BR> <BR> 2. The continuing significant brand building costs covering a range of personal care and branded packaged food products are reflected under 'Other expenses' stated above and in Segment Results under 'FMCG-Others'. <BR> <BR> 3. 18,29,340 Ordinary Shares of Re. 1/- each were issued and allotted under the Company’s Employee Stock Option Schemes during the quarter ended 31st December, 2025. Consequently, the issued and paid-up Share Capital of the Company stands increased to Rs. 1252,89,59,771/- as on 31st December, 2025. <BR> <BR> 4. Exceptional Items of Continuing Operations for the nine months ended 31st December, 2025 of Rs. 266.50 Crores represents : <BR> <BR> a) estimated one-time impact on recognition of past service cost of Rs. 354.58 Crores during the quarter ended 31st December, 2025 with respect to increase in liability of gratuity and compensated absences, primarily arising due to change in definition of wages pursuant to notifications issued by the Ministry of Labour & Employment dated 21st November, 2025 bringing into force the provisions of the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the “New Labour Codes”). The Group continues to monitor the finalisation of rules by the Central and State Governments and clarifications from the Government on other aspects of the New Labour Codes and will account for such developments as needed. <BR> <BR> b) receipt of Rs. 88.08 Crores during the quarter ended 30th September, 2025 on final settlement of the insurance claim towards leaf tobacco stocks, which were destroyed due to fire at a third party owned warehouse in an earlier year. <BR> <BR> 5. Discontinued Operations represents operations of the Hotels Business of the Group (excluding ITC Grand Central, Mumbai) which was demerged pursuant to the Scheme of Arrangement amongst the Company and ITC Hotels Limited and their respective shareholders and creditors under Sections 230 to 232 read with the other applicable provisions of the Companies Act, 2013 (‘the Scheme’) w.e.f. 1st January, 2025, being the Appointed Date and the Effective Date of the Scheme. <BR> <BR> Brief particulars of the Discontinued Operations are given as under (Rs. in Crores): <BR> <BR> Sr. No. - Particulars - 3 Months ended 31.12.2025 (Unaudited) - Corresponding 3 Months ended 31.12.2024 (Unaudited) - Preceding 3 Months ended 30.09.2025 (Unaudited) - 9 Months ended 31.12.2025 (Unaudited) - 9 Months ended 31.12.2024 (Unaudited) – Twelve Months ended 31.03.2025 (Audited) <BR> <BR> a - Revenue from Operations - 0 – 1013.28 - 0 – 0 - 2484.58 - 2484.58 <BR> b - Total Income - 0 – 1028.45 – 0 – 0 – 2517.16 - 2517.16 <BR> c - Total Expenses - 0 – 741.57 – 0 – 0 – 2002.67 - 2002.67 <BR> d - Share of Profit / (Loss) of Associates and Joint Ventures - 0 – 3.53 – 0 – 0 – 11.35 - 11.35 <BR> e - Profit Before Exceptional Items and Tax (b-c+d) - 0 – 290.41 – 0 – 0 – 525.84 - 525.84 <BR> f - Exceptional Items - 0 – (12.18) – 0 – 0 – (16.37) - 15128.81 <BR> g - Tax Expenses - 0 – 74.79 – 0 – 0 – 146.07 - 638.64 <BR> h - Profit from Discontinued Operations (e+f-g) - 0 – 203.44 – 0 – 0 – 363.40 - 15016.01 <BR> <BR> 6. The amalgamation of Sresta Natural Bioproducts Private Limited (SNBPL) and Wimco Limited, wholly owned subsidiaries, with the Company was approved by the Board of Directors on 1st August, 2025. Necessary petitions seeking sanction of the National Company Law Tribunal, Kolkata and Hyderabad Benches, to the said amalgamation have been filed and is pending approval. <BR> <BR> The fair values of assets and liabilities on acquisition of SNBPL and its subsidiaries Fyve Elements LLC, USA and Sresta Global FZE, UAE have been provisionally determined and recorded in accordance with Ind AS 103 on 'Business Combinations' and are reflected in 'FMCG-Others' segment. The financial results of the Group and 'FMCG-Others' segment include those of SNBPL and its subsidiaries with effect from 13th June, 2025. Accordingly, results of the quarter and nine months ended 31st December, 2025 are not comparable with previous periods. <BR> <BR> 7. Prag Agro Farm Limited has ceased to be a wholly owned subsidiary of the Company with effect from 10th December, 2025, consequent to its voluntary liquidation. <BR> <BR> 8. The Board of Directors of the Company have declared an Interim Dividend of <BR> Rs. 6.50 per Ordinary Share of Re. 1/- each (2025 – Rs. 6.50 per Ordinary Share). The Record Date fixed for the purpose of determining entitlement of the Members for the Interim Dividend is Wednesday, 4th February, 2026 and such Dividend will be paid between Thursday, 26th February, 2026 and Saturday, 28th February, 2026 to those Members entitled thereto. <BR> <BR> 9. This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> 2025-04-012025-12-31UnauditedConsolidated660918500000184065000006793250000001961230000007007280000016996000005034400000055990000012885800000138742300000470427400000208897600000-2665000000206232600000460697000007053900000531236000000153109000000000237510000015548410000014852000001569693000001530150000002469100000154513300000245600000012529000000112.2212.210012.2212.21Excise Duty16593400000Other Expenses30430800000Excise Duty50481300000Other Expenses88261000000FMCG - Cigarettes96810800000FMCG - Others61095800000Agri Business38590400000Paperboards, Paper & Packaging22030300000Others13037600000FMCG - Cigarettes286492800000FMCG - Others179691400000Agri Business176206800000Paperboards, Paper & Packaging65399700000Others373097000002315649000007451004000001578910000088775200000215775800000656325200000FMCG - Cigarettes54872900000FMCG - Others4482900000Agri Business4958500000Paperboards, Paper & Packaging1887700000Others1878800000FMCG - Cigarettes164483200000FMCG - Others12860400000Agri Business13841300000Paperboards, Paper & Packaging5215600000Others525410000068080800000201654600000194700000559900000345300000-751300000067540800000208607700000FMCG - Cigarettes112284100000FMCG - Others142820100000Agri Business83470700000Paperboards, Paper & Packaging100093200000Others30991600000469659700000501791700000971451400000FMCG - Cigarettes73313300000FMCG - Others29953500000Agri Business16666400000Paperboards, Paper & Packaging13889600000Others11766700000145589500000627961000002083856000001. ‘Revenue from operations’ should be read as ‘Gross Revenue from sale of products and services’. <BR> <BR> 2. ‘Other Unallocable Expenditure net off Unallocable income’ should be read as ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’. <BR> <BR> 3. In case of 3 months ended 31.12.2025, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (217.66) Crores, Exceptional Items* of Rs. 354.58 Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 102.39 Crores. <BR> <BR> 4. In case of 9 months ended 31.12.2025, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (780.29) Crores, Exceptional Items* of Rs. 266.50 Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 237.51 Crores. <BR> <BR> 5. In case of 3 months ended 31.12.2025 and 9 months ended 31.12.2025, ‘Un-allocable Assets’ includes Nil ‘Discontinued Operations**’ and ‘Unallocated Corporate Assets’ of Rs. 50179.17 Crores. <BR> <BR> 6. In case of 3 months ended 31.12.2025 and 9 months ended 31.12.2025, ‘Un-allocable Liabilities’ includes Nil ‘Discontinued Operations**’ and ‘Unallocated Corporate Liabilities’ of Rs. 6279.61 Crores. <BR> <BR> * Refer note 4 to the Consolidated Financial Results. <BR> ** Refer note 5 to the Consolidated Financial Results. <BR> <BR> Note: As stock options and stock appreciation linked reward units are granted to align the interests of employees with those of shareholders and also to attract and retain talent for the Group as a whole, the charge thereof do not form part of the segment performance reviewed by the Corporate Management Committee. <BR> Items that will not be reclassified to profit or loss642100000642100000Items that will not be reclassified to profit or loss1465300000146530000087800000217200000Items that will be reclassified to profit or loss198600000198600000Items that will be reclassified to profit or loss248000002480000058700000-2123000006942000001485200000